POL Posts: Blogs, Reports & Updates
May 30, 2024

The New Malaria Vaccine May Overdeliver

In October 2022, we had shared information about the approval and launch of a malaria vaccine by the WHO. Recently we received exciting news; the new malaria vaccine is overdelivering on its efficacy. Recent studies have shown that the new vaccine may be effective in prevention of malaria deaths and “all cause deaths” in children by 13%. This is huge. If these results hold, the vaccine would be a major development in pediatric health and malaria control. According to Dr. Steve Taylor, a global health and infectious disease expert, “the vaccine seems to reduce deaths in cases where malaria is only a contributing factor, exacerbating other diseases but not killing the patient itself”. Although there are challenges such as cost and some complexity in administering multiple doses, a significant reduction in malaria-related mortality is anticipated by 2026-2027.

In the interim, until the vaccine is broadly accessible, the use of insecticide-treated mosquito nets remains the most cost-effective intervention for preventing malaria and other vector-borne diseases. Our objective for 2024 is to distribute 15,000 long-lasting insecticide-treated nets, which will benefit approximately 30,000 adults or 55,000 children in Zambia—one of the top 20 countries with the highest malaria incidence and mortality rates. The primary recipients of these nets will include young children, individuals living with HIV and/or TB, HIV-positive pregnant women, and older adults in rural, peri-urban, and urban resource-limited settings.

Thank you for keeping chidlren and families safe from malaria.

Category of this Blog Post 
Post Type 

Add new comment

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.